Sign Up to like & get
recommendations!
1
Published in 2017 at "Scientific Reports"
DOI: 10.1038/s41598-017-04495-x
Abstract: To identify risk factors for infection in patients with diffuse large B cell lymphoma (DLBCL) undergoing rituximab, cyclophosphamide, vincristine, adriamycin and prednisolone (R-CHOP) treatment. All patients with DLBCL who received R-CHOP from 2004–2014 in a…
read more here.
Keywords:
independent predictor;
infection;
large cell;
diffuse large ... See more keywords